PLK1 and cancer: Moreover, the expanding application of cationic arginine-rich peptides as cell-penetrating peptides (CPPs), owing to their reduced toxicity and exceptional ability to cross cancer cell membranes, prompted the incorporation of multiple arginine residues (Arg12) as cell-penetrating cargos for peptide-based PLK1 ligand delivery [34,35].